Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Nabil Amirouchene-Angelozzi"'
Autor:
Giuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, Alessandro Magrì, Carlotta Cancelliere, Giorgio Corti, Carola Negrino, Vito Amodio, Monica Montone, Alice Bartolini, Ludovic Barault, Luca Novara, Claudio Isella, Enzo Medico, Andrea Bertotti, Livio Trusolino, Giovanni Germano, Federica Di Nicolantonio, Alberto Bardelli
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-22 (2019)
Abstract Background Neoantigens that arise as a consequence of tumor-specific mutations can be recognized by T lymphocytes leading to effective immune surveillance. In colorectal cancer (CRC) and other tumor types, a high number of neoantigens is ass
Externí odkaz:
https://doaj.org/article/23b124a3611d4b43958fdd1407aa1693
Autor:
Scott Kopetz, Stefan Kasper, Fernando Rivera, Christophe Tournigand, Yuan Cheng, Priya Deshpande, Denise D'Alessio, Nabil Amirouchene Angelozzi, Ana Bento Pereira da Silva, Neil Howard Segal
Publikováno v:
Journal of Clinical Oncology. 41:TPS272-TPS272
TPS272 Background: Despite the utilization of systemic targeted agents with chemotherapy for mCRC, long-term survival remains poor. Disease progression in mCRC is common, and SOC options are associated with reduced quality of life (QoL) that has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2549a7cabd1fbc39c809d4e7ec83c2f
https://doi.org/10.1200/jco.2023.41.4_suppl.tps272
https://doi.org/10.1200/jco.2023.41.4_suppl.tps272
Autor:
Livio Trusolino, Federica Di Nicolantonio, Alberto Bardelli, Alice Bartolini, Enzo Medico, Alessandro Magrì, Ludovic Barault, Andrea Bertotti, Nabil Amirouchene-Angelozzi, Annalisa Lorenzato, Carola Negrino, Claudio Isella, Monica Montone, Vito Amodio, Giovanni Germano, Giorgio Corti, Giuseppe Rospo, Luca Novara, Carlotta Cancelliere
Publikováno v:
Genome Medicine
Genome Medicine, Vol 11, Iss 1, Pp 1-22 (2019)
Genome Medicine, Vol 11, Iss 1, Pp 1-22 (2019)
BackgroundNeoantigens that arise as a consequence of tumour-specific mutations can be recognized by T lymphocytes leading to effective immune surveillance. In colorectal cancer (CRC) and other tumour types, a high number of neoantigens is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248e92ed2b4267cd3865350304cb5665
http://europepmc.org/articles/PMC6599263
http://europepmc.org/articles/PMC6599263
Autor:
Chloé Raymondie, Marie Schoumacher, Estelle Frisch-Dit-Leitz, Ahmed Dahmani, Nabil Amirouchene-Angelozzi, Sergio Roman-Roman, Didier Decaudin, David Gentien, Guillaume Carita, Fariba Nemati, Géraldine Liot
Publikováno v:
Oncotarget
// Nabil Amirouchene-Angelozzi 1, 6 , Estelle Frisch-Dit-Leitz 1 , Guillaume Carita 2 , Ahmed Dahmani 2 , Chloe Raymondie 2 , Geraldine Liot 3 , David Gentien 4 , Fariba Nemati 2 , Didier Decaudin 2, 5 , Sergio Roman-Roman 1, * , Marie Schoumacher 1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f054565452b0711f5a73a693ae804b
https://doi.org/10.18632/oncotarget.8054
https://doi.org/10.18632/oncotarget.8054
Autor:
Nabil, Amirouchene-Angelozzi1, Marie, Schoumacher2, Marc-Henri, Stern3, Nathalie, Cassoux4, Laurence, Desjardins4, Sophie, Piperno-Neumann5, Olivier, Lantz6, Sergio, Roman-Roman2, Amirouchene-Angelozzi, Nabil1 (AUTHOR), Schoumacher, Marie2 (AUTHOR), Stern, Marc-Henri3 (AUTHOR), Cassoux, Nathalie4 (AUTHOR), Desjardins, Laurence4 (AUTHOR), Piperno-Neumann, Sophie5 (AUTHOR), Lantz, Olivier6 (AUTHOR), Roman-Roman, Sergio2 (AUTHOR)
Publikováno v:
British Journal of Cancer. 11/3/2015, Vol. 113 Issue 9, p1249-1253. 5p. 1 Chart.
Publikováno v:
Cancer Discovery
Recent technological advances in the field of molecular diagnostics (including blood-based tumor genotyping) allow the measurement of clonal evolution in patients with cancer, thus adding a new dimension to precision medicine: time. The translation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5baa335b1e8391b8b6c2a5fa94a3e469
https://pubmed.ncbi.nlm.nih.gov/28729406
https://pubmed.ncbi.nlm.nih.gov/28729406
Autor:
Giulia Lerda, Federica Morano, Salvatore Siena, Mariangela Russo, Alice Bartolini, Ludovic Barault, Federica Maione, Alessandro Magrì, Filippo Pietrantonio, Giovanni Germano, Enrico Giraudo, Monica Montone, Benedetta Mussolin, Maurizio D'Incalci, Silvia Marsoni, Federica Di Nicolantonio, Giulia Siravegna, Giovanni Crisafulli, Alberto Bardelli, Andrea Sartore-Bianchi, Armando Orlandi, Giuseppe Rospo, Filippo de Braud, Roberta Frapolli, Nabil Amirouchene-Angelozzi, Simona Lamba
Publikováno v:
Nature
Molecular alterations in genes involved in DNA mismatch repair (MMR) promote cancer initiation and foster tumour progression. Cancers deficient in MMR frequently show favourable prognosis and indolent progression. The functional basis of the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4ec99754fca8feafa8b5673b8795c6
http://hdl.handle.net/2318/1660203
http://hdl.handle.net/2318/1660203
Autor:
David Gentien, Xavier Sastre, Pascale Mariani, Sergio Roman-Roman, Amaury Dumont, Jacques Camonis, Nabil Amirouchene-Angelozzi, Didier Decaudin, André Nicolas, Guillaume Carita, Fariba Nemati, Sophie Piperno-Neumann, Laurence Desjardins, Nathalie Cassoux
Publikováno v:
Molecular Oncology. 8:1508-1520
Uveal melanoma (UM) is the most common primary tumor of the eye in adults. There is no standard adjuvant treatment to prevent metastasis and no effective therapy in the metastatic setting. We have established a unique panel of 7 UM cell lines from ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5abd4f11f8bb7f0d2aa63814ee5a21bd
https://doi.org/10.1016/j.molonc.2014.06.004
https://doi.org/10.1016/j.molonc.2014.06.004
Autor:
Vittorina Zagonel, Salvatore Siena, Luca Lazzari, Filippo de Braud, Enzo Medico, Paolo Luraghi, Sergio Abrignani, Silvia Marsoni, Anna Sapino, Federica Di Nicolantonio, Fabrizio d'Adda di Fagagna, Alberto Bardelli, Livio Trusolino, Daniele Regge, Nabil Amirouchene-Angelozzi, Andrea Bertotti, Angelo Vanzulli, Emanuela Bonoldi
Publikováno v:
Cancer Research. 79:CT214-CT214
Background The overall survival of mCRC patients has been increased by the availability of new cytotoxic and targeted agents and today potentially by the advent of immunotherapies. However, the impact of these advances has been incremental rather tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0246a12a9ee197219e33238090ed3e3c
https://doi.org/10.1158/1538-7445.am2019-ct214
https://doi.org/10.1158/1538-7445.am2019-ct214
Autor:
Silvia Marsoni, Giovanni Germano, Andrea Sartore Bianchi, Filippo Pietrantonio, Nicola Personeni, Alessio Amatu, Emanuela Bonoldi, Emanuele Valtorta, Ludovic Barault, Federica Di Nicolantonio, Filippo de Braud, Lorenza Rimassa, Armando Santoro, Silvia Ghezzi, Andrea Cassingena, Giovanna Marrapese, Loredana Lupica, Giulia Siravegna, Giuseppe Rospo, Cosimo Martino, Luca Lazzari, Paolo Luraghi, Nabil Amirouchene-Angelozzi, Alberto Bardelli, Salvatore Siena
Publikováno v:
Cancer Research. 79:CT215-CT215
Background. Metastatic colorectal cancer (CRC) remains mostly incurable, with a survival of about two years only. It has been recently proved that CRCs with genetic defects in the mismatch-repair pathway (MMRd), occurring in 15% of early CRC but only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c221cda338a702979e7e9adf164b7737
https://doi.org/10.1158/1538-7445.am2019-ct215
https://doi.org/10.1158/1538-7445.am2019-ct215